Stifel Nicolaus analyst Annabel Samimy maintained a Buy rating on RegenXBio (RGNX – Research Report) today and set a price target of $40.00.
A three-person arbitration panel overseen by Finra Dispute Resolution Services stunned the financial advice industry on ...
The largest arbitration award granted to retail clients is the third ruling against Stifel involving advisor Chuck Roberts.
Stifel Nicolaus analyst Annabel Samimy maintained a Buy rating on Altimmune (ALT – Research Report) today and set a price target of $18.00. The ...
Stifel Nicolaus initiated coverage on shares of Uranium Energy (NYSEAMERICAN:UEC – Free Report) in a report issued on Wednesday, Marketbeat Ratings reports. The firm issued a buy rating on the basic ...
Stifel Nicolaus analyst Jeffrey Stantial reiterated a Buy rating on Vail Resorts (MTN – Research Report) today and set a price target of $217.00. The company’s shares opened t ...
Siegmann Brings Extensive Industry & Investment Experience to StifelST. LOUIS, March 10, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today appointed Jonathan Siegmann as Managing ...
Savaria (TSE:SIS – Free Report) had its price target decreased by Stifel Nicolaus from C$25.00 to C$24.00 in a report ...
Xponential Fitness (XPOF – Research Report) received a Hold rating and a $12.00 price target from Stifel Nicolaus analyst Chris O`Cull ...
Stifel’s broker-dealer clients are served in the United States through Stifel, Nicolaus & Company, Incorporated, including its Eaton Partners and Miller Buckfire business divisions; Keefe ...